兴齐眼药
(300573)
| 流通市值：96.34亿 | | | 总市值：125.42亿 |
| 流通股本：1.88亿 | | | 总股本：2.45亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 505,157,872.57 | 370,121,251.48 | 503,308,315.77 | 390,970,670.92 |
| 应收票据及应收账款 | 262,813,562.32 | 261,811,520.09 | 239,756,857.66 | 272,588,298.64 |
| 其中：应收票据 | 24,449,303.53 | 20,222,233.67 | 17,741,786.94 | 27,729,104.02 |
| 应收账款 | 238,364,258.79 | 241,589,286.42 | 222,015,070.72 | 244,859,194.62 |
| 应收款项融资 | 16,609,796.09 | 16,122,685.19 | 23,254,776.59 | 38,539,232.64 |
| 预付款项 | 10,588,842.92 | 24,426,473.76 | 32,210,809.04 | 36,941,487.9 |
| 其他应收款合计 | 2,030,896.86 | 3,368,323.3 | 3,945,365.22 | 4,563,867.7 |
| 存货 | 166,084,418.58 | 153,598,936.63 | 145,089,102.76 | 149,365,815.14 |
| 其他流动资产 | 273,341.22 | 471,828.64 | 97,704.31 | 31,101.05 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 963,558,730.56 | 829,921,019.09 | 947,662,931.35 | 893,000,473.99 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 投资性房地产 | 11,833,062.26 | 12,066,609.53 | 12,300,156.8 | 12,533,704.07 |
| 固定资产 | 780,580,861.23 | 778,759,890.71 | 776,980,497.1 | 770,348,159.5 |
| 在建工程 | 237,971,380.21 | 196,852,698.13 | 95,759,332.56 | 82,938,849.61 |
| 使用权资产 | 18,313,888.05 | 16,603,238.23 | 15,491,602.91 | 9,475,587.24 |
| 无形资产 | 149,998,413.22 | 134,572,750.75 | 136,718,742.14 | 139,364,119.11 |
| 开发支出 | 63,142,361.84 | 59,611,088.46 | 64,028,044.86 | 59,172,106.46 |
| 长期待摊费用 | 4,164,238.99 | 4,828,576.27 | 5,738,982.52 | 6,649,388.77 |
| 递延所得税资产 | 26,158,917.64 | 22,497,225.08 | 48,830,586.56 | 50,777,995.36 |
| 其他非流动资产 | 30,945,124.89 | 61,930,335.08 | 72,258,641.35 | 48,445,058.98 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,333,108,248.33 | 1,297,722,412.24 | 1,238,106,586.8 | 1,189,704,969.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,296,666,978.89 | 2,127,643,431.33 | 2,185,769,518.15 | 2,082,705,443.09 |
| 流动负债: | | | | |
| 短期借款 | 180,149,416.67 | 200,167,750 | 230,177,500 | 250,692,943.66 |
| 应付票据及应付账款 | 23,067,986.06 | 17,727,124.96 | 18,190,619.6 | 17,324,957.77 |
| 应付账款 | 23,067,986.06 | 17,727,124.96 | 18,190,619.6 | 17,324,957.77 |
| 预收款项 | 104,152.21 | 242,879.25 | 465,248.6 | 473,026.03 |
| 合同负债 | 2,827,449.79 | 3,217,825.55 | 2,362,531.98 | 3,680,917.12 |
| 应付职工薪酬 | 75,599,259.02 | 80,235,267.46 | 75,437,766.05 | 72,975,215.34 |
| 应交税费 | 62,479,496.54 | 40,483,037.41 | 59,815,068.39 | 48,617,171.07 |
| 其他应付款合计 | 108,298,455.58 | 96,080,178.92 | 72,826,583.74 | 86,055,034.63 |
| 一年内到期的非流动负债 | 8,615,686.09 | 6,279,538 | 9,420,575.32 | 7,979,685.99 |
| 其他流动负债 | 20,202,803.41 | 17,049,742.96 | 14,555,257.67 | 20,362,119.04 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 481,344,705.37 | 461,483,344.51 | 483,251,151.35 | 508,161,070.65 |
| 非流动负债: | | | | |
| 租赁负债 | 9,201,018.88 | 8,859,182.95 | 7,686,987.88 | 2,175,896.5 |
| 递延收益 | 62,858,917.91 | 64,132,557.35 | 67,068,751.9 | 68,287,987.08 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 72,059,936.79 | 72,991,740.3 | 74,755,739.78 | 70,463,883.58 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 553,404,642.16 | 534,475,084.81 | 558,006,891.13 | 578,624,954.23 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 175,249,247 | 175,249,247 | 174,424,871 | 174,424,871 |
| 资本公积 | 870,713,441.97 | 866,514,775.56 | 862,019,914.65 | 859,780,189.32 |
| 盈余公积 | 87,624,623.5 | 87,624,623.5 | 59,938,445.57 | 59,938,445.57 |
| 未分配利润 | 609,675,024.26 | 463,779,700.46 | 531,379,395.8 | 409,936,982.97 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,743,262,336.73 | 1,593,168,346.52 | 1,627,762,627.02 | 1,504,080,488.86 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,743,262,336.73 | 1,593,168,346.52 | 1,627,762,627.02 | 1,504,080,488.86 |
| 负债和股东权益合计 | 2,296,666,978.89 | 2,127,643,431.33 | 2,185,769,518.15 | 2,082,705,443.09 |
| 公告日期 | 2025-04-29 | 2025-04-22 | 2024-10-29 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |